| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41388-020-01443-4 |
| P698 | PubMed publication ID | 32879444 |
| P50 | author | Fachao Zhi | Q89029264 |
| Yishi Lu | Q98906858 | ||
| P2093 | author name string | Qian Zhou | |
| Erbo Liang | |||
| Yanqiang Shi | |||
| P2860 | cites work | MYEOV functions as an amplified competing endogenous RNA in promoting metastasis by activating TGF-β pathway in NSCLC | Q64136466 |
| Pyrosequencing protocol using a universal biotinylated primer for mutation detection and SNP genotyping | Q80643394 | ||
| From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer | Q91199443 | ||
| Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis | Q91297699 | ||
| The role of SOX family members in solid tumours and metastasis | Q92634188 | ||
| Net1 and Myeov: computationally identified mediators of gastric cancer | Q24651842 | ||
| Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids | Q27314878 | ||
| Epidemiology of pancreatic cancer | Q28079456 | ||
| SOX9 is required for maintenance of the pancreatic progenitor cell pool | Q28510325 | ||
| ETV4 and Myeov knockdown impairs colon cancer cell line proliferation and invasion | Q33242534 | ||
| The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9]. | Q33338634 | ||
| MethHC: a database of DNA methylation and gene expression in human cancer | Q35253968 | ||
| Hes1: a key role in stemness, metastasis and multidrug resistance | Q36213706 | ||
| Identification of the interplay between SOX9 and S100P in the metastasis and invasion of colon carcinoma | Q36299781 | ||
| Epigenetic regulation of SOX9 by the NF-κB signaling pathway in pancreatic cancer stem cells | Q37179115 | ||
| Boys, girls and shuttling of SRY and SOX9. | Q37202124 | ||
| Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling | Q37301823 | ||
| Sox9 and programming of liver and pancreatic progenitors | Q38103364 | ||
| The DNA-binding specificity of SOX9 and other SOX proteins. | Q38328342 | ||
| Integrative CAGE and DNA Methylation Profiling Identify Epigenetically Regulated Genes in NSCLC. | Q38683345 | ||
| Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer | Q38693071 | ||
| ESE3 Inhibits Pancreatic Cancer Metastasis by Upregulating E-Cadherin | Q38727369 | ||
| HES1 in immunity and cancer | Q38804938 | ||
| Notch pathway activation is associated with pancreatic cancer treatment failure. | Q39022175 | ||
| Aberrations of NEGR1 on 1p31 and MYEOV on 11q13 in neuroblastoma | Q39533835 | ||
| MYEOV is a prognostic factor in multiple myeloma | Q39653790 | ||
| MYEOV (myeloma overexpressed gene) drives colon cancer cell migration and is regulated by PGE2. | Q39689653 | ||
| SOX9 mediates the retinoic acid-induced HES-1 gene expression in human breast cancer cells | Q39868080 | ||
| MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32). | Q40391981 | ||
| Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma | Q41856856 | ||
| MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas | Q44119400 | ||
| Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency | Q46174937 | ||
| Sox9-dependent acinar-to-ductal reprogramming is critical for pancreatic intraepithelial neoplasia formation | Q46179018 | ||
| SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer | Q47616426 | ||
| Upregulated SOX9 expression indicates worse prognosis in solid tumors: a systematic review and meta-analysis | Q49246888 | ||
| DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression. | Q50918212 | ||
| SOX9 regulates ERBB signalling in pancreatic cancer development. | Q53229089 | ||
| MYEOV: A candidate gene for DNA amplification events occurring centromeric toCCND1in breast cancer | Q57287496 | ||
| Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes | Q59334865 | ||
| P921 | main subject | pancreatic cancer | Q212961 |
| P577 | publication date | 2020-09-02 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity |
Search more.